ATE457736T1 - Zusammensetzung aus einem pulmonalen surfactant und einem von tnf stammenden peptid - Google Patents

Zusammensetzung aus einem pulmonalen surfactant und einem von tnf stammenden peptid

Info

Publication number
ATE457736T1
ATE457736T1 AT05767969T AT05767969T ATE457736T1 AT E457736 T1 ATE457736 T1 AT E457736T1 AT 05767969 T AT05767969 T AT 05767969T AT 05767969 T AT05767969 T AT 05767969T AT E457736 T1 ATE457736 T1 AT E457736T1
Authority
AT
Austria
Prior art keywords
tnf
composition
pulmonary surfactant
peptide derived
pulmonary
Prior art date
Application number
AT05767969T
Other languages
English (en)
Inventor
Klaus P Schaefer
Stefan-Lutz Wollin
Ingeborg Muehldorfer
Original Assignee
Nycomed Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nycomed Gmbh filed Critical Nycomed Gmbh
Application granted granted Critical
Publication of ATE457736T1 publication Critical patent/ATE457736T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/191—Tumor necrosis factors [TNF], e.g. lymphotoxin [LT], i.e. TNF-beta
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0082—Lung surfactant, artificial mucus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Peptides Or Proteins (AREA)
AT05767969T 2004-08-06 2005-07-27 Zusammensetzung aus einem pulmonalen surfactant und einem von tnf stammenden peptid ATE457736T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP04103808 2004-08-06
PCT/EP2005/053672 WO2006013183A1 (en) 2004-08-06 2005-07-27 Composition comprising a pulmonary surfactant and a tnf-derived peptide

Publications (1)

Publication Number Publication Date
ATE457736T1 true ATE457736T1 (de) 2010-03-15

Family

ID=34929426

Family Applications (1)

Application Number Title Priority Date Filing Date
AT05767969T ATE457736T1 (de) 2004-08-06 2005-07-27 Zusammensetzung aus einem pulmonalen surfactant und einem von tnf stammenden peptid

Country Status (9)

Country Link
US (1) US8236750B2 (de)
EP (1) EP1781323B1 (de)
JP (1) JP5108515B2 (de)
AT (1) ATE457736T1 (de)
AU (1) AU2005268755B2 (de)
CA (1) CA2575513C (de)
DE (1) DE602005019416D1 (de)
ES (1) ES2339954T3 (de)
WO (1) WO2006013183A1 (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20090060348A (ko) * 2006-09-19 2009-06-11 디스커버리 래보래토리스, 인크. 폐 계면활성제 제제 및 점액 클리어런스 촉진 방법
EP2009023A1 (de) * 2007-06-04 2008-12-31 Rentschler Beteiligungs GmbH Neuartige Peptide und ihre Verwendung bei der Behandlung von Ödemen
AT507953B1 (de) * 2009-03-05 2011-02-15 Apeptico Forschung & Entwicklung Gmbh Verfahren zur vermeidung und zur behandlung einer hyperpermeabilität
AT509267A1 (de) * 2010-01-14 2011-07-15 Apeptico Forschung & Entwicklung Gmbh Organische verbindungen zur regulierung von vektoriellen ionenkanälen
DK2397151T3 (en) 2010-06-21 2015-05-18 Apeptico Forschung & Entwicklung Gmbh The treatment of the vascular complications of diabetes
AT510585B1 (de) * 2010-11-18 2012-05-15 Apeptico Forschung & Entwicklung Gmbh Zusammensetzung umfassend ein peptid und ein hemmstoff der viralen neuraminidase
EP2679239A1 (de) * 2012-06-28 2014-01-01 Apeptico Forschung und Entwicklung GmbH Pharmazeutische Zusammensetzung zur Behandlung der durch Sauerstoffarmut und verringerten Luftdruck vermittelten pulmonalen Form der Höhenkrankheit
AU2014257678A1 (en) * 2013-04-23 2015-10-15 Apeptico Forschung Und Entwicklung Gmbh Lyophilisate containing a cyclic peptide of formula X1-GQRETPEGAEAKPWY-X2
US12004506B2 (en) 2013-04-23 2024-06-11 Apeptico Forschung Und Entwicklung Gmbh Pharmaceutical composition comprising a cyclic peptide of formula X1-GQRETPEGAEAKPWY-X2 and use for extracorporeal lung treatment
CN105188735A (zh) * 2013-04-23 2015-12-23 阿佩普蒂科研究和开发有限责任公司 包含式x1-gqretpegaeakpwy-x2的环肽的药物组合物及其体外处理肺的用途
WO2015132294A1 (en) * 2014-03-04 2015-09-11 Apeptico Forschung Und Entwicklung Gmbh Attenuation of intrapulmonary inflammation
CA2940351A1 (en) 2014-03-18 2015-09-24 Apeptico Forschung Und Entwicklung Gmbh Dry-powder peptide medicament
CN107979996A (zh) * 2015-04-30 2018-05-01 不莱梅大学 新的皮肤医疗和美容护理产品
CN106821982A (zh) * 2017-01-12 2017-06-13 东南大学 一种西那普肽微泡制剂及其制备方法
IL294894A (en) * 2020-05-08 2022-09-01 Apeptico Forschung & Entwicklung Gmbh A peptide for the prevention or treatment of covid-19

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3229179C2 (de) 1982-08-05 1986-04-17 A. Nattermann & Cie GmbH, 5000 Köln Lungensurfactant
DE3369644D1 (en) 1982-11-22 1987-03-12 Teijin Ltd Artificial lung surfactant and remedy for respiratory distress syndrome containing it as active principle
JPS59164724A (ja) 1983-03-10 1984-09-17 Tokyo Tanabe Co Ltd サ−フアクタント及びそれを含有する呼吸窮迫症候群治療剤
CS938384A1 (en) 1983-12-08 1990-08-14 Lachmann Burkhardt Pharmaceutical agent for breathlesness therapy and method of its production
US5104853A (en) 1984-12-11 1992-04-14 California Biotechnology Inc. Alveolar surfactant proteins having cys to ser mutations
US4659805A (en) 1984-12-11 1987-04-21 California Biotechnology, Inc. Recombinant alveolar surfactant protein
US4933280A (en) 1984-12-11 1990-06-12 California Biotechnology Inc. Recombinant DNA sequence encoding Alveolar Surfactant Protein
WO1987006943A1 (en) 1986-05-06 1987-11-19 Children's Hospital Medical Center Pulmonary hydrophobic surfactant-associated protein of 6,000 daltons molecular weight and multimers thereof
WO1988003170A1 (en) 1986-10-24 1988-05-05 Whitsett Jeffrey A Pulmonary hydrophobic surfactant-associated proteins
IT1203873B (it) 1987-04-08 1989-02-23 Chiesi Farma Spa Composizioni farmaceutiche che lo surfattante polmonare naturale, contengono. metodo di preparazione e
US4944941A (en) * 1987-08-07 1990-07-31 Genentech, Inc. Methods and compositions for the treatment of lung conditions
AU625394B2 (en) 1987-11-04 1992-07-09 Byk Gulden Lomberg Chemische Fabrik Gmbh Alveolar surfactant proteins
US5164369A (en) 1988-01-06 1992-11-17 The Scripps Research Institute Pulmonary surfactant protein and related polypeptide
US5260273A (en) 1988-01-06 1993-11-09 The Scripps Research Institute Pulmonary surfactant protein and related polypeptide
AR245141A1 (es) 1988-07-01 1993-12-30 Merrell Dow Pharma Procedimiento de sintesis secuencial o de bloques en fase solida para preparar polipeptidos de estructura helicoidal.
SE8803713D0 (sv) 1988-10-18 1988-10-18 Kabigen Ab Biologically active lipoprotein and its use
DE4418936A1 (de) * 1994-05-31 1996-02-08 Byk Gulden Lomberg Chem Fab Polypeptid
CZ292186B6 (cs) * 1996-01-24 2003-08-13 Altana Pharma Ag Způsob výroby práškového prostředku s obsahem plicní povrchově aktivní látky, práškový prostředek a jeho použití
WO1997035882A1 (en) 1996-03-27 1997-10-02 Ortho Pharmaceutical Corporation Lyophilized pulmonary surfactant peptide compositions
TR199901772T2 (de) * 1997-02-17 1999-09-21 Byk Gulden Lomberg Chemische Fabrik Gmbh
HU227661B1 (hu) * 1998-08-14 2011-10-28 Rudolf Lucas Dr TNF-eredetû peptidek ödéma kezelésére
ATE308976T1 (de) 1998-11-10 2005-11-15 Altana Pharma Ag Lungensurfactant zubereitungen enthaltendes behandlungset
DE19851617A1 (de) * 1998-11-10 2000-05-11 Byk Gulden Lomberg Chem Fab Behandlungsset
JP2003522138A (ja) * 2000-02-11 2003-07-22 アルタナ ファルマ アクチエンゲゼルシャフト 慢性肺疾患の予防および治療のための肺表面活性剤の新規使用
EP1276495B1 (de) 2000-04-12 2006-04-19 ALTANA Pharma AG Verwendung von rekombinantem lungensurfactant zur frühbehandlung von akuten lungenerkrankungen
SE0102055D0 (sv) 2001-06-08 2001-06-08 Astrazeneca Ab New Compounds
ES2346048T3 (es) 2001-10-11 2010-10-08 Nycomed Gmbh Nueva utilizacion de un agente tensioactivo pulmonar.

Also Published As

Publication number Publication date
AU2005268755B2 (en) 2011-04-07
US20070299003A1 (en) 2007-12-27
AU2005268755A1 (en) 2006-02-09
ES2339954T3 (es) 2010-05-27
JP2008509107A (ja) 2008-03-27
CA2575513C (en) 2014-09-16
WO2006013183A1 (en) 2006-02-09
US8236750B2 (en) 2012-08-07
DE602005019416D1 (de) 2010-04-01
CA2575513A1 (en) 2006-02-09
EP1781323A1 (de) 2007-05-09
JP5108515B2 (ja) 2012-12-26
EP1781323B1 (de) 2010-02-17

Similar Documents

Publication Publication Date Title
DE602008002810D1 (de) Peptide zur desensibilisierung gegenüber allergenen
DE602005019416D1 (de) Zusammensetzung aus einem pulmonalen surfactant und einem von tnf stammenden peptid
DE602008002693D1 (de) Vakzine-peptid-kombinationen gegen katzenallergie
EP1791553A4 (de) Zusammensetzungen zur abgabe von peptid yy und pyy agonisten
CR20140465A (es) Proteinas de union a interleuquina-13
IS8371A (is) Notkun breyttra sýklósporína til að meðhöndla HCVsjúkdóma
EP1843776A4 (de) Gereinigte amphile peptid-zusammensetzungen und ihre verwendung
ATE430569T1 (de) Neue arzneimittel zur behandlung von chronisch obstruktiver lungenerkrankung
EP1851237A4 (de) Pharmazeutische zusammensetzungen zur behandlung oder prävention von knochenerkrankungen
IL232501A (en) Peptide or polypeptide-resistant protein analogs and their uses
ECSP045191A (es) "nuevos péptidos como inhibidores de la proteasa serina ns3 del virus de la hepatitis c"
NO20073900L (no) Anvendelse av LGG for fremstilling av et medikament for forebygging eller behandling av respiratoriske sykdommer
DE602007008434D1 (de) Rezeptoren
CL2007000161A1 (es) Compuestos derivados de 2,4-dioxoimidazolidina sustituida, inhibidores de proteinas cinasas; composicion farmaceutica; y uso en el tratamiento de enfermedades tales como cancer.
NO20075074L (no) Kinazolinon T-type-kalsiumkanalantagonister
MX2010002716A (es) Uso de slit, nefrina, efrina o semaforina para el tratamiento de enfermedades de cartilago.
ATE493412T1 (de) Spirohydantoin-aryl-cgrp-rezeptorantagonisten
ATE447551T1 (de) Biphenyloxyessigsäure - derivate zur behandlung von atemwegserkränkungen
NO20076405L (no) Anvendelse av 24-nor-UDCA
DE602005021970D1 (de) Verwendung von peptidverbindungen zur behandlung von schmerzen durch knochenkrebs, chemotherapie- und nucleosid-bedingten schmerzen
DE602006019468D1 (de) Diarylharnstoffe zur behandlung von pulmonaler hypertonie
EP1896050A4 (de) Lkktet- und / oder lkktnt-peptidzusammensetzungen und verfahren
EP1940460A4 (de) Oligodendrocyten-myelin-glycoprotein-zusammensetzungen und verwendungsverfahren dafür
PL1890720T3 (pl) Kompozycje farmaceutyczne zawierające peptydy pochodzące z kazeiny i sposoby ich stosowania
DE502006007982D1 (de) Neue arzneimittelkombinationen zur behandlung von atemwegserkrankungen

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties